Asthma and COPD Market: Increasing Growth Seen in Health Sector

1
Asthma and COPD Market Size is Projected to
Experience Significant Growth from 2017 to 2024.
Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
2
Brief Detail of Asthma and COPD Market

• Rising prevalence of the respiratory diseases,
  growing pathogens in environment leading to
  chronic conditions such as, chronic obstructive
  pulmonary disease (COPD) and asthma are the major
  growth driving factors.
• These conditions require lifelong medications as
  a result medical adherence is extremely
  necessary, in addition, the reduction in quality
  of life are some aspects that fuel the Asthma and
  COPD Market growth over the forecast period.
• These chronic respiratory diseases are caused by
  numerous environmental factors or are genetically
  acquired requires constant care management.
• As per WHO in 2015, approximately 3 million
  deaths were caused due to COPD, being the
  progressive and life-threatening disease of
  lungs, this accounts for around 5 of the total
  global deaths per year.

3

• Moreover, the supporting initiatives by private
  and public institutions adds up to the asthma and
  COPD market size growth during the forecast
  timeframe.
• For instance, the Global Asthma Network (GAN)
  along with the International Union against
  Tuberculosis and lung disease and the
  International Study of Asthma and Allergies in
  Childhood (ISAAC) aims reduction in asthma
  suffering.
• This is done by the improvement in respiratory
  care globally and are more focused on the low and
  middle-income nations. The increase in adoption
  rate of products thereby, provide business growth.

4
Regional Analysis of Asthma and COPD Market

• Inhalers includes metered dose inhalers (MDIs),
  soft mist inhalers (SMIs), and drug powder
  inhalers (DPIs). DPIs accounted for major share
  in 2016 due to the advantages such as less
  patient coordination required, compactness,
  appropriate for emergency circumstances, and
  portability are some aspects that encourages the
  patients buying preferences.
• U.S. led the asthma and COPD market owing to
  strong pipeline for novel therapies,
  technological advancements, and growing disease
  prevalence. According to, the CDC, in 2014,
  around 15.7 million Americans were detected with
  COPD, that accounts for 6.4 people of the total
  population. India and China are growing
  significantly due to increase in disease
  prevalence. These nations have opportunity to
  grow their business rapidly as some of the
  European pharmaceutical companies are on the edge
  of expiration in terms of numerous patents.

5

Browse Full Market Research Report On Asthma and
COPD Market _at_ http//bit.ly/2vhtvFc Request
for an in-depth table of contents for this report
_at_ http//bit.ly/2vshtte
6
Stay In Touch Website www.gminsights.com Soci
al Media